News
New study shows how the microbiome can impact the effectiveness of immunotherapy treatment
Researchers have discovered a new type of gut bacteria, called YB328, that may help cancer treatments work better. This bacterium...
Adjusting Oxaliplatin-based Chemotherapy Doses May Help Reduce Nerve Damage in Colon Cancer Treatment
A recent French study suggests that tailoring chemotherapy doses based on lean body mass (LBM), rather than standard body surface...
Promising New First-Line Treatment for BRAF V600E–Mutated Metastatic Colorectal Cancer
Updated results from the international BREAKWATER phase III trial show that patients with BRAF V600E-mutated metastatic colorectal cancer may live...
Self-Care is Not Selfish!
Self-care has become a buzz word in recent years, and the self-care plan templates that are being used are not...
Phase 3 Trial Finds that a Structured Exercise Program Significantly Improves Survival and Reduces Recurrence in Colorectal Cancer Patients
A randomized phase 3 trial (CHALLENGE, CO.21) conducted by the Canadian Cancer Trials Group found that a 3-year structured exercise...
New Treatment Combination Lowers Risk of Death by Half for Patients with BRAFV600E-Mutated Metastatic Colorectal Cancer
New results from the Phase 3 BREAKWATER clinical trial show that a combination treatment including BRAFTOVI® (encorafenib), cetuximab, and chemotherapy...
Get social
New study shows how the microbiome can impact the effectiveness of immunotherapy treatment
Researchers have discovered a new type of gut bacteria, called YB328, that may help cancer treatments work better. This bacterium...
Adjusting Oxaliplatin-based Chemotherapy Doses May Help Reduce Nerve Damage in Colon Cancer Treatment
A recent French study suggests that tailoring chemotherapy doses based on lean body mass (LBM), rather than standard body surface...
Promising New First-Line Treatment for BRAF V600E–Mutated Metastatic Colorectal Cancer
Updated results from the international BREAKWATER phase III trial show that patients with BRAF V600E-mutated metastatic colorectal cancer may live...
Self-Care is Not Selfish!
Self-care has become a buzz word in recent years, and the self-care plan templates that are being used are not...
Phase 3 Trial Finds that a Structured Exercise Program Significantly Improves Survival and Reduces Recurrence in Colorectal Cancer Patients
A randomized phase 3 trial (CHALLENGE, CO.21) conducted by the Canadian Cancer Trials Group found that a 3-year structured exercise...
New Treatment Combination Lowers Risk of Death by Half for Patients with BRAFV600E-Mutated Metastatic Colorectal Cancer
New results from the Phase 3 BREAKWATER clinical trial show that a combination treatment including BRAFTOVI® (encorafenib), cetuximab, and chemotherapy...
